drugset / Trial / NCT00004468
Study of Topical Calcitriol or Oral Calcitriol in Patients With Psoriasis
Withdrawn
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Boston University · collab
Treatment
Summary
OBJECTIVES: I. Evaluate the long term safety and efficacy of orally administered calcitriol in patients with at least 5% of their body covered with psoriasis. II. Evaluate the long term safety and efficacy of topically administered calcitriol in patients with at least 5% of their body covered with psoriasis. III. Compare the topical calcitriol treatment to the oral calcitriol treatment in these patients.
Timeline
- Start
- 1998-10
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcitriol | Small molecule | — | Topical |